<ѻý>Want Data on Recently Approved Actinic Keratosis Drug? Here You Goѻý> Phase III trial now published in full for topical anti-proliferative treatment Feb 10, 2021
<ѻý>First Immunotherapy Approved for Basal Cell Carcinomaѻý> Objective responses in 27% of previously treated patients who received cemiplimab Feb 10, 2021
<ѻý>Monoclonal Antibody Highly Effective in Phase III Psoriasis Trialѻý> Beats ustekinumab, but main side effect was oral candidiasis Feb 05, 2021
<ѻý>Brain Tumor Risk Upped With Synthetic Progestogenѻý> Absolute risk still low, however, and product not currently approved in U.S. Feb 03, 2021
<ѻý>High Potassium No Threat With Spironolactoneѻý> Despite guidelines, many still monitoring K levels in young women with acne, researchers find Jan 27, 2021
<ѻý>Masculinizing Hormone Therapy Tied to Acne in Transmenѻý> Acne also linked with depression and anxiety; Accutane may be treatment option Jan 20, 2021
<ѻý>Op-Ed: Gym for Surgeons?ѻý> To perform like athletes, surgeons need to train like athletes Dec 26, 2020
<ѻý>Derm Symptoms Signal MIS-C in Kidsѻý> Case series shows mucocutaneous findings in most children Dec 09, 2020
<ѻý>Renewed Concerns About Finasteride and Mental Healthѻý> Database study links popular alopecia treatment with increased risks of suicidality, depression Nov 27, 2020
<ѻý>Eva Mendes Gets Mono-Threadingѻý> A look at the movie star's recent beauty procedure Nov 24, 2020
<ѻý>More Evidence for Ligelizumab in Chronic Hivesѻý> Anti-IgE drug showed improved activity in omalizumab-treated patients with inadequate symptom control Nov 17, 2020
<ѻý>IL-8 Antibody Active in Tumors After PD-1/L1 Blockadeѻý> Clinical benefit in more than a third of patients with anti-IL-8/nivolumab combo Nov 13, 2020
<ѻý>PD-1 Inhibitor Active in Progressive Basal Cell Cancerѻý> Response rate of 20-30% with cemiplimab after post-hedgehog inhibitor progression or intolerance Nov 11, 2020
<ѻý>Watch for Suicidality in Men on Propeciaѻý> Analysis found high number of psychological-related reports Nov 11, 2020
<ѻý>TYK2 Inhibition Promising in Psoriatic Arthritisѻý> Phase II study found significant benefits for two doses of novel agent Nov 10, 2020
<ѻý>Gut Bacteria for Psoriasis; Long-Term Hair Growth; COVID and STDsѻý> Selected presentations from the European Academy of Dermatology and Venereology virtual conference Nov 05, 2020
<ѻý>Nonsteroidal Topical, Nanodrug Active in Psoriasisѻý> Selected presentations from the European Academy of Dermatology and Venereology meeting Nov 04, 2020
<ѻý>Atopic Dermatitis: New Topical Agent, Durable Results With Oralsѻý> Selected abstracts from the European Academy of Dermatology and Venereology Virtual Conference Nov 02, 2020
<ѻý>First-Ever Positive Phase III Trial in Epidermolysis Bullosaѻý> Faster wound healing with oleogel-S10, particularly in most common form of EB Nov 01, 2020
<ѻý>Add Skin Conditions to COVID-19 Long-Hauler Effectsѻý> Persistence beyond 60 days in some cases, especially with pernio/chilblains Oct 30, 2020
<ѻý>Melanoma Survival Benefit Sustained at 5 Years With Adjuvant Comboѻý> Dabrafenib plus trametinib cut relapse risk in half Sep 02, 2020
<ѻý>Demographics Make a Difference in Common Skin Cancersѻý> Study looks at epidemiology of basal versus squamous cell carcinomas Aug 26, 2020
<ѻý>Calcineurin Blockers for Eczema: No Cancer Signal in Big Studyѻý> "Clinicians can use this evidence to counsel and reassure patients" Aug 12, 2020
<ѻý>New Insights Into Radiation-Induced Hair Lossѻý> Total dose and fraction size matter, minoxidil may spur regrowth Aug 05, 2020
<ѻý>Skin Rashes a Clue to COVID-19 Vascular Diseaseѻý> Certain skin manifestations tied to coagulopathy in the sickest patients Aug 05, 2020
<ѻý>Triplet OK'd as First-Line Therapy in Melanomaѻý> Immunotherapy plus targeted combo nets FDA approval in BRAF-mutant population Jul 31, 2020
<ѻý>DPP-4 Inhibitors Tied to Blistering Skin Conditionѻý> Increased risk for bullous pemphigoid modified by patient age, race Jul 22, 2020
<ѻý>Targeting IL-23 Relieves Multiple Symptoms in PsAѻý> Both enthesitis and dactylitis improved with guselkumab treatment in psoriatic arthritis Jul 21, 2020
<ѻý>COVID-19 May Manifest in the Mouth in Some Patientsѻý> Pay attention to those with a rash, small case series from Spain advises Jul 15, 2020
<ѻý>Psoriasis Cream Succeeds in Early Trialѻý> PDE-4 inhibitor helped clear plaque psoriasis in 6 weeks Jul 15, 2020
<ѻý>Audio-Only Telemedicine: Docs Say Payment Falls Shortѻý> Clinicians wonder why the technology used, not a virtual visit's content or complexity, dictates reimbursement Jul 13, 2020
<ѻý>Sobering Data on Risks of Short-Term Oral Corticosteroidsѻý> Short steroid bursts linked to serious adverse events within a month Jul 06, 2020
<ѻý>Minimal Link Between Eczema and Most Cancersѻý> Study finds severe eczema tied to small risk for lymphoma Jun 30, 2020
<ѻý>Cancer Immunotherapy Tied to Severe COVID-19 Outcomesѻý> Nearly threefold increased risk of hospitalization, severe respiratory illness Jun 25, 2020
<ѻý>Psoriatic Arthritis: Outcomes Similar for Cosentyx and Humiraѻý> Primary endpoint of superiority for secukinumab over adalimumab not met in a phase IIIb trial Jun 08, 2020
<ѻý>Once-Daily Abrocitinib Succeeds for Atopic Dermatitisѻý> Oral treatment acts as JAK inhibitor Jun 05, 2020
<ѻý>EULAR 2020: What to Expectѻý> Cancelled due to pandemic but extensive menu of virtual learning planned Jun 02, 2020
<ѻý>Biologics Don't Increase Melanoma Risk... Probablyѻý> Meta-analysis offers some reassurance, but leaves room for doubt May 20, 2020
<ѻý>Face-Aging Selfies Help Modify Risky Skin Behaviors for Teensѻý> Trial looked at effects of a free "UV-selfie" app May 07, 2020
<ѻý>6-Week Keytruda Safe, Effective in Melanomaѻý> Schedule gets FDA approval for all adult indications Apr 30, 2020